Clinical study patient id: (b)(6).It was reported that on (b)(6) 2022, a 25mm masters valve was selected for an implant.Intra-operative bleeding was noted due to complex surgical repair.Post-implant, the patient was transfused 2 units pack red blood cells (prbc), 6 units platelets and 6 units plasma.Heparin was administered with the following activated clotting time (act) levels act's: at 19:45 112 seconds , at 21:15 467 seconds , at 21:30 487 seconds , at 21:45 720 seconds , at 22:15 632 seconds, at 22:45 536 seconds, at 23:45 123 seconds.The patient's international normalized ratio (inr) was pre-op on (b)(6) 1.1, post-op on (b)(6) 1.2, at discharge on (b)(6) 2.5, current on (b)(6) 2.7.The issue was reported to be resolved with sequelae of blood loss anemia with no further treatment planned.The patient remained hemodynamically stable throughout the procedure.The patient was reported to have been discharged home in stable condition.
|